Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.75
-0.03 (-3.50%)
Bozor ochiq: Aug 12, 2026, 2:01 PM EDT
0.79
+0.01 (1.54%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
MIRA Pharmaceuticals, Inc. ikkita nevrologik va neyropsixiatrik kasalliklarni davolashga qaratilgan ikkita nevrologiya dasturi bilan preklinik bosqichdagi farmatsevtika ishlab chiqaruvchi kompaniya sifatida faoliyat yuritadi. Kompaniya Ketamir-2 uchun AQSh, Kanada va Meksikada eksklyuziv huquqlarga ega bo'lib, bu keyingi avlod og'iz orqali yuboriladigan NMDA retseptorlari modulyatori bo'lib, u 1-bosqich klinik sinovlarini yakunlagan. Shuningdek, u og'iz orqali yuboriladigan farmatsevtika marixuanasi MIRA-55ni taklif etadi, bu tashvish va kognitiv pasayishdan aziyat chekayotgan kattalar bemorlarni davolash uchun tekshirilmoqda, ko'pincha demensiyaning dastlabki bosqichlari bilan bog'liq; va SKNY-1, semirish va nikotin ta'siriga bog'liqlikni davolash uchun preklinik bosqichda. Kompaniya ilgari MIRA1a Therapeutics, Inc. nomi bilan tanilgan. MIRA Pharmaceuticals, Inc. 2020 yilda tashkil etilgan va Mayami, Florida shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Itzchak Angel Ph.D. | Chief Scientific Advisor |
| Mr. Andriy Mushak C.P.A. | Chief Financial Officer |
| Mr. Erez Aminov | CEO & Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-06 | 8-K | form8-k.htm |
| 2026-07-31 | 8-K | form8-k.htm |
| 2026-07-28 | DEF 14A | formdef14a.htm |
| 2026-07-10 | 8-K | form8-k.htm |
| 2026-07-06 | 8-K | form8-k.htm |
| 2026-06-25 | 8-K | form8-k.htm |
| 2026-06-17 | 8-K | form8-k.htm |
| 2026-06-08 | 8-K | form8-k.htm |
| 2026-06-04 | 8-K | form8-k.htm |
| 2026-05-27 | 8-K | form8-k.htm |